All jobs

Photocure

Pharmaceutical Manufacturing · United States

Website

About Photocure

The Bladder Cancer Company

Industry
Pharmaceutical Manufacturing
Company size
51-200 employees
Headquarters
Oslo
Founded
1993
Company type
Public Company

About Photocure Photocure is a commercial diagnostic company with global reach, committed to driving progress in uro-oncology precision diagnostics, delivering meaningful advances for patients with urological cancers. Our unique core technology has led to better health outcomes for patients worldwide. The company aims to provide an array of transformative solutions that help physicians with timely diagnostic information, to inform more personalized decisions on how best to manage each individual patient. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit www.photocure.com/news

On this account Photocure posts about uro-oncology and company activity. All information presented on this account is for informational purposes only and is not intended as a substitute for informed medical advice or recommendations from healthcare professionals. Please consult a healthcare professional for more information about your condition and medicinal products.

Specialties

  • pharmaceuticals
  • urology
  • uro-oncology
  • bladder cancer
  • and precision diagnostics

Company locations

  • Hoffsveien 4, Oslo, 0275, NO

  • 202 Carnegie Center, Suite 101, Princeton, New Jersey 08540, US

  • Marc-Chagall Straße 2, Düsseldorf, North Rhine-Westphalia 40477, DE

Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.

Business areas

  • Health Care
  • Biotechnology
  • Pharmaceutical

On LinkedIn

Followers
6,762
People linked to this company
137

People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.

Employer category

Other employer

Estimated from the company profile. This category has not been confirmed by the employer.